Feature Story
GE Suit Hushes Scientist Critical of Omniscan
by Jeff Gerth, ProPublica, and Jon Ungoed-Thomas, The Sunday Times - December 19, 2009 4:00 pm EST
Henrik Thomsen, a Danish radiologist who is credited as one of the clinicians who alerted patients and regulators to the potential risks of Omniscan for renal patients, refuses to speak anywhere in England on the possible risks of Omniscan. The reason is that he faces another kind of storm: GE Healthcare is suing him for libel in the UK High Court. Read More »
Major Stories
FDA Advised to Tighten Restrictions on GE and Covidien MRI Drugs
by Jeff Gerth, ProPublica - December 9, 2009 3:35 pm EST
An FDA advisory panel recommends effectively banning the use of GE’s Omniscan and Covidien’s Optimark in patients with severe kidney disease.
FDA to Take a Second Look at Warnings on MRI Drugs
by Jeff Gerth, ProPublica - October 16, 2009 2:37 pm EST
After issuing a blanket warning about the risk to patients with kidney disease, regulators will reconsider whether to treat some imaging agents differently.
Feds May Tighten Rules on Omniscan, a GE MRI Drug
by Jeff Gerth, ProPublica - December 2, 2009 5:55 pm EST
An FDA review says MRI imaging drugs may be even riskier for kidney patients than it believed previously.
Specter of MRI Disease Haunts GE
by Jeff Gerth, ProPublica - October 15, 2009 4:16 pm EST
Many MRI patients are injected with a GE dye to enhance images. If they have weak kidneys, they might develop a rare and sometimes fatal disease
The Doctors' Viewpoints
Unless otherwise noted, you can republish our articles and graphics (but not our photographs) for free. You just have to credit us and link to us, and you can’t edit our material or sell it separately. (We're licensed under